7Holders
0.00%Avg. Weight
$0.0BTotal Value
0New Buys
Price Chart
NBP
NBP차트 불러오는 중
Smart Money Score
Holders (7)
13F · by weight| # | Investor | Weight | Shares | Value | Activity |
|---|---|---|---|---|---|
| 1 |  Steve Cohen Point72 Asset Management LP | 0.00% | 1,389,403 | $3.42M | HOLD |
| 2 |  Jim Simons (Estate) Renaissance Technologies LLC | 0.00% | 272,412 | $670,134 | HOLD |
| 3 |  Ken Griffin Citadel Advisors LLC | 0.00% | 166,616 | $409,875 | HOLD |
| 4 |  Goldman Sachs Goldman Sachs Asset Management | 0.00% | 112,463 | $276,659 | HOLD |
| 5 |  State Street State Street Global Advisors | 0.00% | 370,107 | $910,463 | HOLD |
| 6 |  BlackRock BlackRock Inc | 0.00% | 627,496 | $1.54M | HOLD |
| 7 |  JPMorgan Chase JPMorgan Asset Management | 0.00% | 57,489 | $128,775 | HOLD |
Insider Trades (17)
View all| Insider | Title | Type | Shares | Value | Date |
|---|---|---|---|---|---|
| Lin Liwei Lorraine | General Counsel | BUY | 254,780 | $0.5M | 7/8/2026 |
| Hagler Mark Arnold | Chief Commercial Officer | BUY | 949,050 | $1.8M | 7/8/2026 |
| Gupta Srishti | Chief Executive Officer | BUY | 3,000,000 | $6.0M | 7/6/2026 |
| Xu Cong Claire | SVP, Clinical Development | SELL | 12,432 | -- | 7/4/2026 |
| Xu Cong Claire | SVP, Clinical Development | SELL | 5,405 | -- | 7/4/2026 |
| Xu Cong Claire | SVP, Clinical Development | SELL | 4,485 | $0.0M | 7/6/2026 |
| Fu Wei | Director | BUY | 725,140 | $1.8M | 6/29/2026 |
| Fu Wei | Director | BUY | 1,087,720 | $2.7M | 6/29/2026 |
| Fu Wei | Director | BUY | 1,010,100 | -- | 6/29/2026 |
| Cao Sean Wuxiong | Chief Bus. Development Officer | BUY | 181,290 | $0.3M | 6/22/2026 |